Regenicin's total assets for Q1 2023 were $11.86M, an increase of 0.55% from the previous quarter. RGIN total liabilities were $18.07M for the fiscal quarter, a 2.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.